Pneumococcal carriage among indigenous Warao children in Venezuela: Serotypes, susceptibility patterns, and molecular epidemiology

Clinical Infectious Diseases

Volumn 45, Issue 11, 2007, Pages 1427-1434

  Rivera Olivero, Ismar A ^a   Bogaert, Debby ^c,e   Bello, Teresita ^a   Del Nogal, Berenice ^b   Sluijter, Marcel ^c   Hermans, Peter W M ^d   De Waard, Jacobus H ^a  

^a Hospital Vargas de Caracas   (Venezuela)

^b Hospital de Ninos J M de los Rios   (Venezuela)

^c SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PNEUMOCOCCUS VACCINE; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM ISOLATION; CHILD; DEMOGRAPHY; GENOTYPE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MOLECULAR EPIDEMIOLOGY; NEWBORN; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; THROAT CULTURE; VENEZUELA; AGE DISTRIBUTION; AMERICAN INDIAN; CLASSIFICATION; DRUG EFFECT; EPIDEMIOLOGY; HETEROZYGOTE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MULTIDRUG RESISTANCE; PRESCHOOL CHILD;

AGE DISTRIBUTION; ANTI-BACTERIAL AGENTS; CARRIER STATE; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EPIDEMIOLOGY, MOLECULAR; HUMANS; INDIANS, SOUTH AMERICAN; INFANT; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE; VENEZUELA;

EID: 38449089543     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/522984     Document Type: Article

References (42)

1. World Health Organization. State of the art of new vaccines: research and development: acute respiratory infections, bacterial respiratory infections, Streptococcus pneumoniae. 2004. Available at: http://www.who.int/ vaccineresearch/documents/newvaccines/en/index2.html. Accessed 15 April 2005.
2. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1997; 46:1-24.
3. Butler JC, Schuchat A. Epidemiology of pneumococcal infections in the elderly. Drugs Aging 1999; 15(Suppl 1):11-9.
4. Hansman D, Morris S, Gregory M, McDonald B. Pneumococcal carriage amongst Australian aborigines in Alice Springs, Northern Territory. J Hyg (Lond) 1985; 95:677-84.
5. Davidson M, Parkinson, AJ, Bulkow LR, Fitzgerald MA, Peters HV, Parks DJ. The epidemiology of invasive pneumococcal disease in Alaska, 1986-1990: ethnic differences and opportunities for prevention. J Infect Dis 1994; 170:368-76.
6. Davidson M, Schraer CD, Parkinson AJ. Invasive pneumococcal disease in an Alaska Native population, 1980 through 1986. JAMA 1989; 261:715-8.
7. Bogaert D, de Grott R, Hermans P. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis 2004; 4:144-54.
8. Sampaio AP, Brandileone M, Laval C, Guerra M, Guimaraes J, Di Fabio J. Genetic relationship between streptococcus pneumoniae isolates from nasopharyngeal and cerebrospinal fluid of two infants with pneumococcal meningitis. J Clin Microbiol 2003; 41:3970-2.
9. McCullers JA, Tuomanen EI. Molecular pathogenesis of pneumococcal pneumonia. Front Biosci 2001; 6:D877-89.
10. O'Brien KL, Walters MI, Sellman J, et al. Severe pneumococcal pneumonia in previously healthy children: the role of preceding influenza infection. Clin Infect Dis 2000; 30:784-9.
11. Fuchs SC, Fischer GB, Black RE, Lanata C. The burden of pneumonia in children in Latin America. Paediatr Respir Rev 2005; 6:83-7.
12. Fernandez de Larrea C, Fandino C, Lopez D, et al. Tuberculosis in subjects under 15 years of age in the population of Warao in Venezuela. Invest Clin 2002; 43:35-48.
13. MSDS. Anuario epidemiológico 2003. Available at: http://www.msd.org.ve. Accessed 14 May 2005.
14. O'Brien KL BM, Dagan R, Yagupsky P, et al. Evaluation of a medium (STGG) for transport and optimal recovery of Streptococcus pneumoniae from nasopharyngeal secretions collected during field studies. J Clin Microbiol 2001; 39:1021-4.
15. Ruoff K, Whiley RA, Beighton D. Streptococcus. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH, eds. Manual of clinical microbiology. 8th ed. Washington, DC: ASM Press, 2003:1227-41.
16. Clinical and Laboratory Standards Institute (CLSI)/NCCLS. Performance standards for antimicrobial susceptibility testing. 15th informational supplement. CLSI/NCCLS document M100-S15. Wayne, PA: CLSI, 2005.
17. Van Steenbergen TJ, Colloms SD, Hermans PW, de Graaff J, Plasterk RH. Genomic DNA fingerprinting by restriction fragment end labeling. Proc Natl Acad Sci U S A 1995; 92:5572-6.
18. Hermans PW, Sluijter M, Hoogenboezem T, Heersma H, van Belkum A, de Groot R. Study of five different DNA fingerprint techniques for molecular typing of Streptococcus pneumoniae strains. J Clin Microbiol 1995; 33:1606-12.
19. Sluijter M, Faden H, de Groot R, et al. Molecular characterization of pneumococcal nasopharynx isolates collected from children during their first 2 years of life. J Clin Microbiol 1998; 36:2248-53.
20. Bogaert D, Ha NT, Sluijter M, Lemmens N, De Groot R, Hermans PW. Molecular epidemiology of pneumococcal carriage among children with upper respiratory tract infections in Hanoi, Vietnam. J Clin Microbiol 2002; 40:3903-8.
21. Bogaert D, Veenhoven RH, Sluijter M, et al. Molecular epidemiology of pneumococcal colonization in response to pneumococcal conjugate vaccination in children with recurrent acute otitis media. J Clin Microbiol 2005; 43:74-83.
22. Hermans PW, Sluijter M, Dejsirilert S, et al. Molecular epidemiology of drug-resistant pneumococci: toward an international approach. Microb Drug Resist 1997; 3:243-51.
23. Overweg K, Bogaert D, Sluijter M, et al. Genetic relatedness within serotypes of penicillin-susceptible Streptococcus pneumoniae isolates. J Clin Microbiol 2000; 38:4548-53.
24. Pneumococcal Molecular Epidemiological Network. Available at: http://www.sph.emory.edu/PMEN/pmen_clone_collection.html. Accessed March 2005.
25. Cortese MM, Wolff M, Almeido-Hill J, Reid R, Ketcham J, Santosham M. High incidence rates of invasive pneumococcal disease in the White Mountain Apache population. Arch Intern Med 1992; 152:2277-82.
26. Gratten M, Manning K, Dixon J, et al. Upper airway carriage by Haemophilus influenzae and Streptococcus pneumoniae in Australian aboriginal children hospitalized with acute lower respiratory infection. Southeast Asian J Trop Med Public Health 1994; 25:123-31.
27. Torzillo PJ, Gratten M. Conjugate pneumococcal vaccines for aboriginal children in Australia. Med J Aust 2000; 173(Suppl):S51-3.
28. Perozo-Mena A, Castellano-González M, Avila-Roo Y, Ginestre-Pérez M, y Fuenmayor-Boscan A. Streptococcus pneumoniae: estado de portador en niños preescolares y susceptibilidad a los antimicrobianos. Boletín de la Sociedad Venezolana de Microbiología 2000; 20:5-15.
29. Quintero B, Araque M. Serotype profile and antibiotyping of Streptococcus pneumoniae strains isolated from nasal carriage in pediatric patients. Invest Clin 2006; 47:17-26.
30. Dagan R, Barkai G, Leibovitz E, Dreifuss E, Greenberg D. Will reduction of antibiotic use reduce antibiotic resistance? The pneumococcus paradigm. Pediatr Infect Dis J 2006; 25:981-6.
31. Malhotra-Kumar S, Lammens C, Coenen S, Van Herck K, Goossens H. Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study. Lancet 2007; 369:482-90.
32. Melander E, Molstad S, Persson K, Hansson H, Soderstrom M, Ekdah LK. Previous antibiotic consumption and other risk factors for carriage of penicillin-resistant Streptococcus pneumoniae in children. Eur J Clin Microbiol Infect Dis 1998; 17:834-8.
33. Pallares R, Fenoll A, Linares J; The Spanish Pneumococcal Infection Study Network. The epidemiology of antibiotic resistance in Streptococcus pneumoniae and the clinical relevance of resistance to cephalosporins, macrolides and quinolones. Int J Antimicrob Agents 2003; 22(Suppl 1):S15-24.
34. Schrag SJ, Pena C, Fernandez J. Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage: a randomized trial. JAMA 2001; 286:49-56.
35. Bogaert D, Engelen, MN, Timmers-Reker AJ, et al. Pneumococcal carriage in children in The Netherlands: a molecular epidemiological study. J Clin Microbiol 2001; 39:3316-20.
36. Dagan R, O'Brien L. Modeling the association between pneumococcal carriage and child-care center attendance. Clin Infect Dis 2005; 40:1215-22.
37. Nunes S, Sa-Leao R, Carrico J, et al. Trends in drug resistance, serotypes, and molecular types of Streptococcus pneumoniae colonizing preschool-age children attending day care centers in Lisbon, Portugal: a summary of 4 years of annual surveillance. J Clin Microbiol 2005; 43:1285-93.
38. Whitney CG, Pilishvili T, Farley MM, et al. Effectiveness of sevenvalent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet 2006; 368:1495-502.
39. Dagan RN, Givon-Lavi O, Zamir M, et al. Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers. J Infect Dis 2002; 185:927-36.
40. Black SB, Shinefield HR, Ling S, et al. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatr Infect Dis J 2002; 21:810-5.
41. Coles CL, Kanungo R, Rahmathullah L. Pneumococcal nasopharyngeal colonization in young South Indian infants. Pediatr Infect Dis J 2001; 20:289-95.
42. Singleton RJ, Hennessy TW, Bulkow LR, et al. Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 2007; 297:1784-92.